CME Group Inc. $CME Shares Sold by Xponance Inc.

Xponance Inc. lessened its stake in shares of CME Group Inc. (NASDAQ:CME) by 6.8% during the third quarter, Holdings Channel.com reports. The fund owned 53,317 shares of the financial services provider’s stock after selling 3,902 shares during the period. Xponance Inc.’s holdings in CME Group were worth $14,406,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in CME. Empowered Funds LLC raised its stake in shares of CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after buying an additional 1,037 shares in the last quarter. Daymark Wealth Partners LLC bought a new stake in CME Group in the second quarter worth about $237,000. Arkadios Wealth Advisors lifted its holdings in CME Group by 43.1% in the 2nd quarter. Arkadios Wealth Advisors now owns 3,159 shares of the financial services provider’s stock valued at $871,000 after acquiring an additional 951 shares during the last quarter. Hantz Financial Services Inc. boosted its position in shares of CME Group by 83.8% during the 2nd quarter. Hantz Financial Services Inc. now owns 329 shares of the financial services provider’s stock valued at $91,000 after purchasing an additional 150 shares in the last quarter. Finally, Premier Path Wealth Partners LLC grew its stake in shares of CME Group by 8.7% in the 2nd quarter. Premier Path Wealth Partners LLC now owns 1,616 shares of the financial services provider’s stock worth $445,000 after purchasing an additional 129 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Trading Up 1.0%

Shares of NASDAQ CME opened at $319.50 on Friday. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a one year low of $248.53 and a one year high of $322.57. The business has a 50-day moving average price of $287.63 and a two-hundred day moving average price of $275.97. The firm has a market capitalization of $115.21 billion, a PE ratio of 28.63, a PEG ratio of 3.70 and a beta of 0.27.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm’s quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.52 EPS. As a group, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date is Tuesday, March 10th. This is a positive change from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is currently 44.80%.

Insider Activity at CME Group

In other news, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the sale, the chief executive officer directly owned 65,804 shares in the company, valued at $17,737,468.20. The trade was a 27.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Dennis Suskind sold 748 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the transaction, the director directly owned 2,699 shares in the company, valued at approximately $809,700. The trade was a 21.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 30,248 shares of company stock worth $8,355,450. 0.30% of the stock is currently owned by company insiders.

Key CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Rothschild & Co Redburn raised their target price on shares of CME Group from $300.00 to $333.00 and gave the stock a “neutral” rating in a report on Thursday, February 12th. UBS Group restated a “neutral” rating and issued a $310.00 target price on shares of CME Group in a report on Friday, February 6th. The Goldman Sachs Group upped their target price on CME Group from $264.00 to $266.00 and gave the company a “sell” rating in a report on Monday, February 9th. JPMorgan Chase & Co. increased their price target on CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a research report on Thursday, February 5th. Finally, Bank of America boosted their price objective on CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $299.53.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.